127 filings
Page 3 of 7
8-K
2r56 kln6cum
10 Mar 16
Anthera Pharmaceuticals Provides Business Update and Reports 2015 Fourth Quarter and Fiscal Year Financial Results
12:00am
8-K
m1yqdk1 p0n
8 Mar 16
Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer
12:00am
8-K
t4xf1jc kxrcx
17 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
xltzy24
29 Jan 16
Departure of Directors or Certain Officers
12:00am
8-K
kncn73aj46 5au
8 Jan 16
Departure of Directors or Certain Officers
12:00am
8-K
dpx82 3a2
6 Nov 15
Anthera Pharmaceuticals Provides Business Update and Reports Third Quarter 2015 Financial Results
12:00am
8-K
bfizdp 0f9n
14 Sep 15
Anthera Announces Termination of Blisibimod Partnership in Japan by Zenyaku
12:00am
8-K
pohcyvbt zwtosn
17 Aug 15
Entry into a Material Definitive Agreement
12:00am
8-K
o8x46p9j
10 Aug 15
Anthera Pharmaceuticals Reports 2015 Second Quarter and Operational Update
12:00am
8-K
en5eh
13 Jul 15
Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
12:00am
8-K
f400gm9 vm
21 May 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
zv3 z5p0rdqghfy
11 May 15
Anthera Pharmaceuticals Reports 2015 First Quarter and Operational Update
12:00am
8-K
s3k9f46 yd
9 Apr 15
Departure of Directors or Certain Officers
12:00am
8-K
keixc2df00hxqev3sbc
20 Mar 15
Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
12:00am
8-K
jfwlci1 2640ojcrk
16 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
vpxaj
16 Mar 15
Anthera Pharmaceuticals Reports 2014 Fourth Quarter and Fiscal Year Financial Results, Operational Update and Recent Event Highlights
12:00am
8-K
73l5ey6lpjcc
11 Feb 15
Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase 3 Trial with Blisibimod for Systemic Lupus Erythematosus
12:00am
8-K
7yl1u4b6xiratyd
28 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
d6d5 jbg8rlw
7 Jan 15
Anthera Pharmaceuticals Announces Appointment of Klara A. Dickinson as Senior Vice President, Chief Regulatory Officer
12:00am
8-K
fogvv
30 Dec 14
Termination of a Material Definitive Agreement
12:00am